[go: up one dir, main page]

SI1119363T1 - Zmes karnitina in inositol fosfata za uporabo kot dietetična prehrana in zdravilo - Google Patents

Zmes karnitina in inositol fosfata za uporabo kot dietetična prehrana in zdravilo

Info

Publication number
SI1119363T1
SI1119363T1 SI200030711T SI200030711T SI1119363T1 SI 1119363 T1 SI1119363 T1 SI 1119363T1 SI 200030711 T SI200030711 T SI 200030711T SI 200030711 T SI200030711 T SI 200030711T SI 1119363 T1 SI1119363 T1 SI 1119363T1
Authority
SI
Slovenia
Prior art keywords
carnitine
drug
containing composition
dietary supplement
composition useful
Prior art date
Application number
SI200030711T
Other languages
English (en)
Inventor
Claudio Cavazza
Original Assignee
Sigma - Tau
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma - Tau filed Critical Sigma - Tau
Publication of SI1119363T1 publication Critical patent/SI1119363T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
SI200030711T 1999-04-22 2000-04-19 Zmes karnitina in inositol fosfata za uporabo kot dietetična prehrana in zdravilo SI1119363T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999RM000248A IT1306133B1 (it) 1999-04-22 1999-04-22 Composizione comprendente una carnitina ed un inositolfosfato, utilequale integratore dietetico o medicamento.
PCT/IT2000/000158 WO2000064426A2 (en) 1999-04-22 2000-04-19 Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug

Publications (1)

Publication Number Publication Date
SI1119363T1 true SI1119363T1 (sl) 2005-10-31

Family

ID=11406708

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200030711T SI1119363T1 (sl) 1999-04-22 2000-04-19 Zmes karnitina in inositol fosfata za uporabo kot dietetična prehrana in zdravilo

Country Status (26)

Country Link
US (1) US6565876B1 (sl)
EP (1) EP1119363B1 (sl)
JP (1) JP2002542282A (sl)
KR (1) KR20010053023A (sl)
CN (1) CN1359295A (sl)
AR (1) AR023391A1 (sl)
AT (1) ATE299370T1 (sl)
AU (1) AU776591B2 (sl)
BR (1) BR0006076A (sl)
CA (1) CA2335015C (sl)
DE (1) DE60021247T2 (sl)
DK (1) DK1119363T3 (sl)
EE (1) EE200000742A (sl)
ES (1) ES2243254T3 (sl)
HU (1) HU227357B1 (sl)
IL (1) IL140164A0 (sl)
IS (1) IS5763A (sl)
IT (1) IT1306133B1 (sl)
NO (1) NO20006429L (sl)
PL (1) PL197885B1 (sl)
PT (1) PT1119363E (sl)
SI (1) SI1119363T1 (sl)
SK (1) SK19322000A3 (sl)
TN (1) TNSN00083A1 (sl)
TR (1) TR200003737T1 (sl)
WO (1) WO2000064426A2 (sl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1316997B1 (it) * 2000-03-02 2003-05-26 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento di vasculopatie,che comprende propionil l-carnitina e coenzima q10.
DE10032964B4 (de) * 2000-07-06 2017-10-12 Beiersdorf Ag Verwendung von Kreatin in kosmetischen oder dermatologischen Zubereitungen
DE10129502A1 (de) * 2001-06-19 2003-01-09 Beiersdorf Ag Verwendung von Carnitin und/oder einem oder mehreren Acyl-Carnitinen zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Steigerung der Ceramidbiosynthese
US8173618B2 (en) * 2003-07-25 2012-05-08 University Of Massachusetts Formulations for reducing neuronal degeneration
US20090169585A1 (en) * 2003-10-23 2009-07-02 Resveratrol Partners, Llc Resveratrol-Containing Compositions And Their Use In Modulating Gene Product Concentration Or Activity
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
CA2601641A1 (en) * 2005-03-18 2006-09-28 Oxyplus, Inc. Calcium salt of myo-inositol 1,6:2,3:4,5 tripyrophosphate as an allosteric effector of hemoglobin
ES2280136B1 (es) * 2006-02-17 2008-08-16 Universitat De Les Illes Balears Asociacion a dosis fija de fitato y zinc.
JP5281268B2 (ja) * 2007-10-31 2013-09-04 花王株式会社 筋力向上剤
US8597640B2 (en) * 2007-10-31 2013-12-03 University Of Massachusetts Lowell Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging
KR20110083628A (ko) * 2008-11-11 2011-07-20 시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이. 셀룰라이트의 치료에 유용한 화합물
SG10201503032UA (en) * 2010-06-16 2015-06-29 Sigma Tau Ind Farmaceuti Acetyl-carnitine for use in a method for increasing neurogenesis in neural tissue
ES2495666B1 (es) * 2013-03-15 2015-08-10 Laboratoris Sanifit, S.L. Uso de derivados con enlaces c-o-p en pacientes con fallo renal
KR102141971B1 (ko) * 2018-11-12 2020-08-06 주식회사 노암 항암용 조성물
US20220226286A1 (en) * 2019-05-23 2022-07-21 Ekyj Consulting Ii, Llc Compositions and methods for the treatment and mitigation of alcohol-induced skin flushing

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5626849A (en) * 1995-06-07 1997-05-06 Reliv International, Inc. Weight loss composition for burning and reducing synthesis of fats
EP1021177A4 (en) * 1997-02-04 2002-05-15 John V Kosbab COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF VASCULAR DEGENERATIVE DISEASES
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US5904924A (en) * 1997-11-04 1999-05-18 Oncologics, Inc. Green nutritional powder composition

Also Published As

Publication number Publication date
CA2335015C (en) 2008-03-18
KR20010053023A (ko) 2001-06-25
WO2000064426A2 (en) 2000-11-02
ITRM990248A1 (it) 2000-10-22
IS5763A (is) 2000-12-08
AU4313500A (en) 2000-11-10
HUP0102926A2 (hu) 2002-03-28
EE200000742A (et) 2002-04-15
ATE299370T1 (de) 2005-07-15
DE60021247T2 (de) 2006-04-27
IT1306133B1 (it) 2001-05-30
AU776591B2 (en) 2004-09-16
TR200003737T1 (tr) 2001-07-23
NO20006429D0 (no) 2000-12-15
WO2000064426A3 (en) 2001-05-25
DE60021247D1 (de) 2005-08-18
AR023391A1 (es) 2002-09-04
PL346160A1 (en) 2002-01-28
EP1119363B1 (en) 2005-07-13
US6565876B1 (en) 2003-05-20
CA2335015A1 (en) 2000-11-02
TNSN00083A1 (fr) 2005-11-10
JP2002542282A (ja) 2002-12-10
SK19322000A3 (sk) 2001-06-11
HUP0102926A3 (en) 2002-12-28
BR0006076A (pt) 2001-03-20
HU227357B1 (en) 2011-04-28
ES2243254T3 (es) 2005-12-01
PL197885B1 (pl) 2008-05-30
CN1359295A (zh) 2002-07-17
PT1119363E (pt) 2005-09-30
NO20006429L (no) 2001-02-20
EP1119363A2 (en) 2001-08-01
DK1119363T3 (da) 2005-10-17
IL140164A0 (en) 2002-02-10

Similar Documents

Publication Publication Date Title
GB9916536D0 (en) Nutritional or pharmaceutical compositions
EG24066A (en) Novel quinuclidine derivatives and medicinal compositions containing the same
IL144977A0 (en) Pyrrolotriazine derivatives and pharmaceutical compositions containing the same
HUP0203378A3 (en) Pharmaceutical compounds and pharmaceutical compositions containing them
IL138899A0 (en) Amidene derivatives and pharmaceutical compositions containing the same
IL140862A0 (en) Thiobenzimidazole derivatives and pharmaceutical compositions containing the same
IL146703A0 (en) Dietary of pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
IL143920A0 (en) 3-heteroarylidenyl-2-indolinone derivatives and pharmaceutical compositions containing the same
PL343627A1 (en) Medicinal compositions
IL164022A0 (en) Phosphate derivatives of fluoroxindole and pharmaceutical compositions containing the same
HUP0102926A3 (en) Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug
HUP0101381A3 (en) Benzofurylpyrone derivatives and pharmaceutical compositions containing them
HUP0202788A3 (en) Indolyl-3-glyoxylic acid derivatives serving as antitumor agents and pharmaceutical compositions containing them
EP1166786A4 (en) MEDICAL COMPOSITIONS
IL147214A0 (en) 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same
HUP0105204A3 (en) Substituted phenethylamine derivatives and pharmaceutical compositions containing them
HUP0200747A3 (en) Pharmaceutical compounds and pharmaceutical compositions containing them
IL148807A0 (en) Tetrahydrothiopyran derivatives and pharmaceutical compositions containing the same
GB2354153B (en) Dietary supplement
HUP0000042A3 (en) Omega-3-fatacid and vitamin containing meet product
HUP0200055A3 (en) 16-hydroxyestrienes and pharmaceutical compositions containing the same
HUP0200468A3 (en) Resorcinol derivatives and pharmaceutical compositions containing them
GB9820815D0 (en) Improvementsin or relating to nutritional and pharmaceutical compositions
GB9920054D0 (en) Dietary composition
HUP0201443A3 (en) 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives and pharmaceutical compositions containing them